麥角巴生 的英文怎麼說
中文拼音 [màijiǎobāshēng]
麥角巴生
英文
ergobasine- 麥 : 名詞1 [植物學] (麥類統稱) a general term for wheat barley etc : 黑麥 rye; 蕎麥 buckwheat2 [植物...
- 角 : 角Ⅰ名詞1 (牛、羊、 鹿等頭上長出的堅硬的東西) horn 2 (古時軍中吹的樂器) bugle; horn 3 (形狀像...
- 巴 : Ⅰ動詞1 (急切盼望) hope earnestly; wait anxiously for 2 (粘住; 緊貼) cling to; stick to 3 (爬...
- 生 : Ⅰ動詞1 (生育; 生殖) give birth to; bear 2 (出生) be born 3 (生長) grow 4 (生存; 活) live;...
-
Conclusions the frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non ? ergot - derived dopamine agonists, as compared with control subjects
結論:與對照組相比,服用培高利特或者卡麥角林的患者臨床上發生重要瓣膜返流的頻率顯著增加,但服用非麥角?生的多巴胺受體激動劑的患者瓣膜返流的發生率卻未增加。Background case reports and echocardiographic studies suggest that the ergot - derived dopamine agonists pergolide and cabergoline, used in the treatment of parkinson ' s disease and the restless legs syndrome, may increase the risk of cardiac - valve regurgitation
背景:病例報告和超聲心動圖研究提示,用於治療帕金森病和不寧腿綜合征的藥物?麥角?生物,多巴胺受體激動劑培高利特和卡麥角林,可能增加發生心臟瓣膜返流的風險。Methods we performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for parkinson ' s disease ( pergolide, 64 patients ; cabergoline, 49 ; and non ? ergot - derived dopamine agonists, 42 ) and 90 control subjects
方法:我們用超聲心動圖對155例正在服用多巴胺受體激動劑( 64例服用培高利特, 49例服用卡麥角林, 42例服用非麥角?生的多巴胺受體激動劑)治療帕金森病的患者和90例對照組進行了一項流行調查。Results clinically important regurgitation ( moderate to severe, grade 3 to 4 ) in any valve was found with significantly greater frequency in patients taking pergolide ( 23. 4 % ) or cabergoline ( 28. 6 % ) but not in patients taking non ? ergot - derived dopamine agonists ( 0 % ), as compared with control subjects ( 5. 6 % )
結果:與對照組相比( 5 . 6 % ) ,服用培高利特( 23 . 4 % )或者卡麥角林的患者( 28 . 6 % ) ,臨床上發生重要的任何瓣膜的返流(中到重度, 3級到4級)的頻率顯著升高,而服用非麥角?生的多巴胺受體激動劑的患者( 0 % )瓣膜返流的發生率卻未增加。Conclusions in this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac - valve regurgitation
結論:研究發現使用多巴胺受體激動劑培高利特和卡麥角林可增加新發生的心臟瓣膜返流的風險。分享友人